608 dose
SSGJ-608-AS-III-01
Phase 3 small_molecule active
Quick answer
608 dose for Ankylosing Spondylitis is a Phase 3 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Ankylosing Spondylitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active